BUY Sun Pharmaceutical Industries Ltd. — Aastha Jain, Hem Securities
byAastha Jain, Hem SecuritiesHorizon: NA (inferred Swing (≤2wk))1 Sept 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Sun Pharma participated in a White House ceremony, announcing agreements with the U.S. government to prioritize access to affordable medicines. The company committed to Most Favored Nation (MFN) prici
BSE · Company Update·1 Sept · 3d ago
3 advisors have active short-term BUY calls on this stock
Advisor consensus · adjacent horizon·30 Jul · 1mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Sun Pharmaceutical Industries
- BUY — Sumeet Bagadia, Choice Broking23 Oct 2026 · Same day · target ₹1,790 · Expired
- BUY — HSBC Securities7 Oct 2026 · ~1 year · target ₹2,100 · Active
- SELL — Rajesh Palviya, Axis Securities5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY — Sumeet Bagadia, Choice Broking29 Sept 2026 · Same day · target ₹1,875 · Expired
- BUY — 360 One Capital29 Sept 2026 · ~1 year · target ₹2,250 · Active
More from Aastha Jain, Hem Securities
- BUY Chennai Petroleum Corporation23 Oct 2026 · ~2 weeks · target ₹1,570 · Active
- BUY Zensar Technologies23 Oct 2026 · Next day · target ₹550 · Active
- BUY Tata Consultancy Services23 Oct 2026 · ~2 weeks · target ₹2,600 · Target hit
- BUY Tata Elxsi22 Oct 2026 · Same day · target ₹3,930 · Expired
- BUY The Indian Hotels Company22 Oct 2026 · ~2 weeks · target ₹820 · Active

